Concerning neuroprotective therapy for Parkinson's disease

被引：0
|
作者：
Uitti, R. J. [1 ]
Wszolek, Z. K. [1 ]
机构：
[1] Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL 32224 USA
来源：
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT | 2006年 / 70期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Studying potential neuroprotective therapy for Parkinson's disease is conceptually problematic because of the heterogenous nature of the Parkinson's syndrome and complexities in operational definitions for neuroprotection. The current literature concerning neuroprotection provides no convincing evidence of any treatment as definitively neuroprotective in Parkinson's disease. Recent clinical trials and novel trial designs are reviewed that may identify meaningful therapy, resulting in maintenance of neurological function and quality of life for persons with Parkinson's disease.
引用
收藏
页码：433 / 437
页数：5
相关论文
共 50 条
  • [1] Neuroprotective therapy for Parkinson's disease
    Koller, WC
    EXPERIMENTAL NEUROLOGY, 1997, 144 (01) : 24 - 28
  • [2] Neuroprotective and neurorestorative therapy in Parkinson's disease
    JimenezJimenez, FJ
    Molina, JA
    REVISTA DE NEUROLOGIA, 1997, 25 : S185 - S193
  • [3] Obstacles to the Development of a Neuroprotective Therapy for Parkinson's Disease
    Stocchi, Fabrizio
    Olanow, C. Warren
    MOVEMENT DISORDERS, 2013, 28 (01) : 3 - 7
  • [4] Fractalkine as a Neuroprotective Therapy in a Model of Parkinson's Disease
    Pabon, M. M.
    Jernberg, J.
    Hudson, C. E.
    Bachstetter, A.
    Gemma, C.
    Bickford, P. C.
    CELL TRANSPLANTATION, 2010, 19 (03) : 355 - 356
  • [5] Necessity of a neuroprotective therapy in the treatment of Parkinson's disease (PD)
    Ibanez Ivonne, Pedroso
    Rodriguez Anubis, Aguiar
    Maria Luisa, Bringas Vega
    Sanchez Mario, Alvarez
    Gonzalez Lazaro, Alvarez
    de la Fe Amado, Diaz
    Sanchez Arnoldo, Padron
    REVISTA MEXICANA DE NEUROCIENCIA, 2008, 9 (04): : 298 - 302
  • [6] Trial Designs Used to Study Neuroprotective Therapy in Parkinson's Disease
    Lang, Anthony E.
    Melamed, Eldad
    Poewe, Werner
    Rascol, Olivier
    MOVEMENT DISORDERS, 2013, 28 (01) : 86 - 95
  • [7] Interest in predictive testing for Parkinson's disease:: Impact of neuroprotective therapy
    Dahodwala, N.
    Connolly, J.
    Farmer, J.
    Stern, M. B.
    Jennings, D.
    Siderowf, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 (08) : 495 - 499
  • [8] Neuroprotective Treatments in Parkinson's Disease
    Cinar, Elif
    Cakmakli, Gul Yalcin
    Te, Banu Cahide
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (04) : 189 - 197
  • [9] Is DBS neuroprotective in Parkinson's disease?
    Markaki, E.
    Ellul, J.
    Theodoropoulou, A.
    Kyriazopoulou, V.
    Constantoyannis, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 664 - 664
  • [10] Mitochondrial therapy for Parkinson's disease: Neuroprotective pharmaconutrition may be disease-modifying
    Kones, Richard
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2010, 2 : 185 - 198
12345